Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

236 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Optimal testing parameters for blood cultures.
Cockerill FR 3rd, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, Schleck CD, Ilstrup DM, Washington JA 2nd, Wilson WR. Cockerill FR 3rd, et al. Among authors: washington ja 2nd. Clin Infect Dis. 2004 Jun 15;38(12):1724-30. doi: 10.1086/421087. Epub 2004 May 25. Clin Infect Dis. 2004. PMID: 15227618
Ceftazidime resistance in Hafnia alvei.
Thomson KS, Sanders CC, Washington JA 2nd. Thomson KS, et al. Among authors: washington ja 2nd. Antimicrob Agents Chemother. 1993 Jun;37(6):1375-6. doi: 10.1128/AAC.37.6.1375. Antimicrob Agents Chemother. 1993. PMID: 8328790 Free PMC article.
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.
Jones RN, Fuchs PC, Washington JA 2nd, Gavan TL, Murray PR, Gerlach EH, Thornsberry C. Jones RN, et al. Among authors: washington ja 2nd. Diagn Microbiol Infect Dis. 1990 Nov-Dec;13(6):499-507. doi: 10.1016/0732-8893(90)90082-7. Diagn Microbiol Infect Dis. 1990. PMID: 2126232
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.
Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA 2nd. Jones RN, et al. Among authors: washington ja 2nd. J Clin Microbiol. 1989 Dec;27(12):2758-66. doi: 10.1128/jcm.27.12.2758-2766.1989. J Clin Microbiol. 1989. PMID: 2531756 Free PMC article.
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Jones RN, Aldridge KE, Barry AL, Fuchs PC, Gerlach EH, Pfaller MA, Washington JA 2nd. Jones RN, et al. Among authors: washington ja 2nd. Diagn Microbiol Infect Dis. 1988 Aug;10(4):221-40. doi: 10.1016/0732-8893(88)90094-6. Diagn Microbiol Infect Dis. 1988. PMID: 3072151 Clinical Trial.
236 results